Searched for
AGILA BIOTECH
How Grofers survived to deliver and tell the taleThe decision of founders to pivot to an inventory-led model paid off for the firm.- We have niche strategy in US, leadership strategy in Australia: Shashank Sinha, Strides Shasun“Strides has one of the best compliance standards in the Indian generic pharma industry.”
- We're here to stay, open to buy right portfolio: Rajiv Malik, President, MylanMylan is committed to staying in India and plans to build up its presence gradually while remaining open to acquisition, says Rajiv Malik.
- Under pressure, cabinet defers decision on FDI curbs in pharmaDIPP suggestion seeks to prevent MNCs from taking control of existing critical care drug companies.
- Strides Arcolab to reward shareholders with up to Rs 800/share payout post Agila saleStrides will be returning cash to investors after the crash in rupee bumped up the money it is getting for selling its Agila unit to Mylan ...
- Strides, Pfenex in pact to develop six biosimilar productsStrides Arcolab and Pfenex Inc have inked a pact to form a JV to develop and manufacture six biosimilar products for the global market.
- Strides Arcolab sells Agila Specialities to Mylan for $1600Pharmaceutical company Strides Arcolab will sell its specialities division, Agila Specialities to Mylan for $1600 million in cash and a pot...
- Strides inks pact with Malaysia's Bio-XCell for new facilityDrug firm Strides Arcolab said it has entered into an agreement with Bio-XCell Sdn Bhd for establishing a facility in Malaysia.
Load More